| 1 |
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al. · Clinical Cancer Research
Open access |
17 Jan 2019 |
699 |
| 2 |
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
Theodore Oliphant, Michael J. Engle, Grant E. Nybakken et al. · Nature Medicine
Open access |
24 Apr 2005 |
521 |
| 3 |
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
Nicole Sherry, William Hagopian, Johnny Ludvigsson et al. · The Lancet
Open access |
30 Jun 2011 |
494 |
| 4 |
Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine
Maria J.W.D. Vosjan, Lars R. Perk, Gerard W.M. Visser et al. · Nature Protocols
|
25 Mar 2010 |
449 |
| 5 |
Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
Scott J. Balsitis, Katherine L. Williams, Ruben Lachica et al. · PLoS Pathogens
Open access |
11 Feb 2010 |
416 |
| 6 |
Absolute and relative nonlinear optical coefficients of KDP, KD*P, BaB/sub 2/O/sub 4/, LiIO/sub 3/, MgO:LiNbO/sub 3/, and KTP measured by phase-matched second-harmonic generation
Robert C Eckardt, Hisashi Masuda, Yinxiang Fan et al. · IEEE Journal of Quantum Electronics
|
May 1990 |
410 |
| 7 |
Paramagnetic lanthanide complexes as PARACEST agents for medical imaging
Mark Woods, Donald E. Woessner, A. Dean Sherry · Chemical Society Reviews
ReviewOpen access |
2006 |
391 |
| 8 |
Combination immunotherapy: a road map
Patrick Alexander Ott, Frank Stephen Hodi, Howard L. Kaufman et al. · Journal for ImmunoTherapy of Cancer
Open access |
10 Feb 2017 |
386 |
| 9 |
Structural basis of West Nile virus neutralization by a therapeutic antibody
Grant E. Nybakken, Theodore Oliphant, Syd Johnson et al. · Nature
Open access |
Sep 2005 |
362 |
| 10 |
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer
Hope S. Rugo et al. · JAMA Oncology
Open access |
23 Jan 2021 |
353 |
| 11 |
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia
Geoffrey L. Uy et al. · Blood
Open access |
15 Sep 2020 |
332 |
| 12 |
Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus
Pankaj Pal, Kimberly A. Dowd, James D. Brien et al. · PLoS Pathogens
Open access |
18 Apr 2013 |
314 |
| 13 |
Targeting CD73 in the tumor microenvironment with MEDI9447
Carl M. Hay, Erin Sult, Qihui Huang et al. · OncoImmunology
Open access |
11 Jul 2016 |
292 |
| 14 |
Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity
Deryk T. Loo et al. · Clinical Cancer Research
|
21 May 2012 |
287 |
| 15 |
Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor Cells In vitro and Controls Tumor Expansion In vivo via Low-Affinity Activating Fcγ Receptors
Jeffrey B. Stavenhagen, Sergey N. Gorlatov, Nadine Tuaillon et al. · Cancer Research
Open access |
15 Sep 2007 |
280 |
| 16 |
Implantable Myoelectric Sensors (IMESs) for Intramuscular Electromyogram Recording
Richard F ff Weir, Phil R. Troyk, Glen A. DeMichele et al. · IEEE Transactions on Biomedical Engineering
Open access |
29 Sep 2008 |
276 |
| 17 |
Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis
Kathryn E. Lafond et al. · PLoS Medicine
ReviewOpen access |
Mar 2021 |
269 |
| 18 |
Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants
Whitney E. Purtha, Thomas F. Tedder, Syd Johnson et al. · The Journal of Experimental Medicine
Open access |
12 Dec 2011 |
267 |
| 19 |
In Situ Detection of Apoptosis by the TUNEL Assay: An Overview of Techniques
Deryk T. Loo · Methods in molecular biology
Book chapter |
15 Oct 2010 |
266 |
| 20 |
Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma
Paul A. Moore, Wenjun Zhang, G. Jonah Rainey et al. · Blood
|
8 Feb 2011 |
263 |
| 21 |
A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs
Gopi Shankar, Charles E. Pendley, Kathryn E. Stein · Nature Biotechnology
|
May 2007 |
262 |
| 22 |
Selective dysregulation of the FcγIIB receptor on memory B cells in SLE
Meggan C. Mackay, Anfisa Stanevsky, Tao Wang et al. · The Journal of Experimental Medicine
Open access |
21 Aug 2006 |
253 |
| 23 |
Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties
Jeffrey L. Nordstrom, Sergey N. Gorlatov, Wenjun Zhang et al. · Breast Cancer Research
Open access |
30 Nov 2011 |
251 |
| 24 |
Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes
William Hagopian, Robert J. Ferry, Nicole Sherry et al. · Diabetes
Open access |
25 Jun 2013 |
249 |
| 25 |
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
Sacha Gnjatic, Vincenzo Bronte, Laura Rosa Brunet et al. · Journal for ImmunoTherapy of Cancer
Open access |
12 May 2017 |
243 |
| 26 |
Trends in Next-Generation Sequencing and a New Era for Whole Genome Sequencing
Sang Tae Park, Jayoung Kim · International Neurourology Journal
Open access |
28 Nov 2016 |
234 |
| 27 |
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors
Yung‐Jue Bang, Giuseppe Giaccone, S.-A. Im et al. · Annals of Oncology
Open access |
25 Jan 2017 |
228 |
| 28 |
Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2
Soila Sukupolvi-Petty, S. Kyle Austin, Michael J. Engle et al. · Journal of Virology
Open access |
Jul 2010 |
224 |
| 29 |
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
Jayakumar Narayanan Vadakekolathu et al. · Science Translational Medicine
Open access |
3 Jun 2020 |
218 |
| 30 |
p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
Lars R. Perk, Maria J.W.D. Vosjan, Gerard W.M. Visser et al. · European Journal of Nuclear Medicine and Molecular Imaging
Open access |
17 Sep 2009 |
216 |
| 31 |
The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
Bimmi Shrestha, James D. Brien, Soila Sukupolvi-Petty et al. · PLoS Pathogens
Open access |
Apr 2010 |
213 |
| 32 |
Effector Cell Recruitment with Novel Fv-based Dual-affinity Re-targeting Protein Leads to Potent Tumor Cytolysis and in Vivo B-cell Depletion
Syd Johnson, Stephen P. Burke, Ling Ju Huang et al. · Journal of Molecular Biology
|
10 Apr 2010 |
197 |
| 33 |
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial
Daniel V.T. Catenacci et al. · The Lancet Oncology
|
9 Jul 2020 |
192 |
| 34 |
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells
Yohan Kim, Kyojin Kang, Seung Bum Lee et al. · Journal of Hepatology
|
19 Sep 2018 |
184 |
| 35 |
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study
Waasila Jassat et al. · The Lancet HIV
Open access1,574 authors |
4 Aug 2021 |
181 |
| 36 |
Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform
Muneera Al-Hussaini, Michael P. Rettig, Julie Ritchey et al. · Blood
Open access |
3 Nov 2015 |
179 |
| 37 |
A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates
Gurunadh Reddy Chichili, Ling Ju Huang, Hua Li et al. · Science Translational Medicine
|
27 May 2015 |
174 |
| 38 |
Preclinical Development of MGC018, a Duocarmycin-based Antibody–drug Conjugate Targeting B7-H3 for Solid Cancer
Juniper A. Scribner et al. · Molecular Cancer Therapeutics
|
23 Sep 2020 |
163 |
| 39 |
TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML
Jayakumar Narayanan Vadakekolathu et al. · Blood Advances
Open access |
15 Oct 2020 |
156 |
| 40 |
Monoclonal antibodies capable of discriminating the human inhibitory Fcγ‐receptor IIB (CD32B) from the activating Fcγ‐receptor IIA (CD32A): biochemical, biological and functional characterization
Maria-Concetta Verı́, Sergey N. Gorlatov, Hua Li et al. · Immunology
Open access |
26 Mar 2007 |
156 |
| 41 |
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
Charu Aggarwal et al. · Journal for ImmunoTherapy of Cancer
Open access |
Apr 2022 |
151 |
| 42 |
T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors
Apostolia Maria Tsimberidou, Karlyle Van Morris, Henry Hiep Vo et al. · Journal of Hematology & Oncology
Open access |
30 Jun 2021 |
151 |
| 43 |
The genome of Diuraphis noxia, a global aphid pest of small grains
Scott J. Nicholson, Michael L. Nickerson, Michael C. Dean et al. · BMC Genomics
Open access |
4 Jun 2015 |
150 |
| 44 |
Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
James D. Brien, S. Kyle Austin, Soila Sukupolvi-Petty et al. · Journal of Virology
Open access |
12 Aug 2010 |
145 |
| 45 |
Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017–18 (PHIRST): a population cohort study
Cheryl A. Cohen et al. · The Lancet Global Health
Open access |
18 May 2021 |
143 |
| 46 |
Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program
Kavita M. Dhodapkar, Devi Kanti Banerjee, John Edward Connolly et al. · The Journal of Experimental Medicine
Open access |
14 May 2007 |
143 |
| 47 |
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial
Jason J. Luke et al. · Nature Medicine
Open access |
19 Oct 2023 |
139 |
| 48 |
Complement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific Manner
Erin Mehlhop, Camilo Ansarah-Sobrinho, Syd Johnson et al. · Cell Host & Microbe
Open access |
Dec 2007 |
137 |
| 49 |
Dual-Affinity Re-Targeting proteins direct T cell–mediated cytolysis of latently HIV-infected cells
Julia Sung et al. · Journal of Clinical Investigation
Open access |
27 Sep 2015 |
134 |
| 50 |
Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein ProtectIn Vivovia Fcγ Receptor and Complement-Dependent Effector Mechanisms
Matthew R. Vogt, Kimberly A. Dowd, Michael J. Engle et al. · Journal of Virology
Open access |
15 Sep 2011 |
132 |